Diseases, Conditions, Syndromes

Anti-TB drugs can increase risk of TB re-infection

Current treatments for tuberculosis (TB) are very effective in controlling TB infection caused by Mycobacterium tuberculosis (Mtb). They don't, however, always prevent reinfection. Why this happens is one of the long-standing ...

Diseases, Conditions, Syndromes

A breakthrough in tuberculosis research

Often causing no symptoms in carriers of the disease, worldwide tuberculosis (TB) infects eight to ten million people every year, kills two million, and it is highly contagious as it is spread through coughing and sneezing.

Diseases, Conditions, Syndromes

Scientists discover how tuberculosis hijacks the immune system

Scientists have unlocked a key element in understanding how human lungs fight tuberculosis (TB). They hope their research findings, which were published today in the international peer reviewed journal Immunity, will help ...

Medical research

Gene therapy makes mice breath easier

Researchers from Boston University School of Medicine (BUSM) have discovered a new gene therapy that may prevent the progression of emphysema. The study, which appears on-line in the Journal of Clinical Investigation, describes ...

Surgery

Researchers discover indicator of lung transplant rejection

Research by scientists at Dignity Health St. Joseph's Hospital and Medical Center's Norton Thoracic Institute was published in the July 12, 2017 issue of Science Translational Medicine titled "Zbtb7a induction in alveolar ...

Health

E-cigarette vapor condensate toxic to alveolar macrophages

(HealthDay)—Electronic cigarette (e-cigarette) vapor condensate (ECVC) is significantly more toxic to alveolar macrophages than e-cigarette liquid (ECL), according to a study published online Aug. 13 in Thorax.

Immunology

Mitophagy in macrophages is a key step toward pulmonary fibrosis

Idiopathic pulmonary fibrosis is a devastating disease, and recently approved therapies have limited efficacy. Lungs become damaged with fibrotic scarring, and the median length of survival after diagnosis is three to five ...

page 1 from 2